Latest Eisai News & Updates

See the latest news and media coverage for Eisai. We track all announcements, press releases, and industry mentions in real time, all in one place.

Eisai

Japanese pharmaceutical company

eisai.com

Headquarters: Bunkyo-Ku, Japan
Company type: Public company
Number of employees: 1,000–5,000
Industry: Pharmaceuticals

Last updated Today

Latest news about Eisai

In short: Eisai achieved strong growth for its Alzheimer’s drug Leqembi and announced a 1 trillion yen investment plan to expand its R&D pipeline.

Company announcements

April 3 Eisai

Eisai opens new Global Capability Centre

The IT hub in Visakhapatnam, India, standardizes global IT operations and drives digital transformation. An opening ceremony celebrated its launch.

February 20 Eisai

Eisai receives human capital awards for third year

Eisai earns 'Thought Leaders of Human Capital 2025' and 'Human Capital Management Excellence 2025 Gold Award' for excellent management and disclosure.

January 26 Eisai

Eisai announces FDA acceptance of LEQEMBI IQLIK sBLA

The application for subcutaneous starting dose in early Alzheimer’s is under priority review with action date May 24, 2026.

January 21 Eisai

Eisai ranks 36th in Global 100 sustainability list

It marks Eisai's tenth inclusion and highest rank among global pharmaceutical companies. Evaluation based on UN SDGs, sustainable revenue, and investment.

Media coverage

July 30 Yahoo

Alzheimer’s patients given boost as second drugmaker enters NHS talks

Hopes that the first drugs shown to slow Alzheimer’s disease could be rolled out on the NHS have risen after a second manufacturer entered price...

July 29 日刊薬業

Leqembi, global sales of 29.3 billion yen

Games are starting to be used in medical settings Otonichi Thursday "Invisible work supports lives" (16) 7/30 04:59 AI drug discovery, developing with diverse modalities Astellas, modified proteins and TPD etc. 7/30 04:30 Kumamoto earthquake, Sanwa Chemical etc. factory operations suspended Pharmaceutical distribution no major issues [free] 7/29 20:59 Sawai Pharmaceutical's Kyushu No. 2 factory water leak Kumamoto earthquake, no impact on drug supply [free] 7/29 20:58...

July 29 Nikkei

Eisai, Alzheimer's drug 'Lecanemab' sales up 27% in April-June 2026

Eisai announced on the 29th that sales revenue for the April-June 2026 period for the Alzheimer's disease treatment drug 'Lecanemab (product name Leqembi)' jointly developed with U.S. Biogen increased by 27% year-on-year to 29.3 billion yen (preliminary figure). Sales grew in the United States and Japan. Eisai and Biogen...

July 28 Yahoo

NHS in talks to roll out Alzheimer’s drug

The NHS has entered negotiations to roll out the first drugs shown to slow Alzheimer’s disease.

Never miss news about Eisai

Track Eisai and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Eisai competitors & trending companies

Browse news for competitors to Eisai and other trending companies.